A review based on a quick and heavily compromised cost-effectiveness evaluation conducted in secret with a threat to delist unless the company accepted a significant price reduction. Apparently, this is what constitutes a pricing negotiation in 2019. …
Latest Video
New Stories
-
New gene therapy partnership between bluebird bio and Novo Nordisk
October 22, 2019 - - Latest News -
Finance points to 'improved PBS costings accuracy' in annual report
October 22, 2019 - - Latest News -
Extension for MA chair as members prepare for AGM
October 22, 2019 - - Latest News -
Greg Hunt: Nine days from 'agreement' to listing
October 22, 2019 - - Latest News -
It was like 'throwing darts at a dartboard while blindfolded'
October 21, 2019 - - Latest News -
Payments in advance and a higher interest rate
October 21, 2019 - - Latest News -
Greg Hunt unlikely to lose any sleep over that list
October 21, 2019 - - Latest News